◆英語タイトル:Ambry Genetics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011828
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secure file upload. It offers clinical resources such as cancer test overview videos, webinars, clinical tools, clinician guides, other publications, and ambryport 2.0 tutorial videos. The company also provides patient resources for cancer, cardiology, exome, general genetics, neurology, and microarray. Ambry Genetics is headquartered in Aliso Viejo, California, the US.
Ambry Genetics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ambry Genetics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Partnerships 13
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
Acquisition 14
Konica Minolta Acquires Ambry Genetics 14
Ambry Genetics Acquires Progeny Software 16
Ambry Genetics Corp – Key Competitors 17
Ambry Genetics Corp – Key Employees 18
Ambry Genetics Corp – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Feb 18, 2016: Ambry Genetics Unveils Its Super Lab, One of the Largest, Most State-of-the-Art Commercial Laboratories in the World 20
Corporate Communications 22
Mar 24, 2016: Charles Dunlop of Ambry Genetics Assumes Role of President; Dr. Aaron Elliott Named CEO 22
Government and Public Interest 23
Apr 18, 2017: Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism 23
Product News 24
Mar 08, 2016: Ambry Genetics Launches AmbryShare, the Largest Disease-Specific Public Database of Sequenced Human Genomes, Increasing the Understanding of Hereditary Breast and Ovarian Cancer 10 Fold 24
Other Significant Developments 26
Feb 21, 2017: Ambry Genetics Launches New Site for Cohort Recruitment 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Key Facts 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambry Genetics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Ambry Genetics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
Konica Minolta Acquires Ambry Genetics 14
Ambry Genetics Acquires Progeny Software 16
Ambry Genetics Corp, Key Competitors 17
Ambry Genetics Corp, Key Employees 18
Ambry Genetics Corp, Subsidiaries 19